Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.

Sexton, James D; Nichols, Charles D; Hendricks, Peter S

Sexton, James D; Nichols, Charles D; Hendricks, Peter S.

Afiliación

Sexton JD; Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States.
Nichols CD; Department of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, New Orleans, LA, United States.
Hendricks PS; Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States.

Front Psychiatry ; 10: 896, 2019.

Article en En | MEDLINE | ID: mdl-32116806

Palabras clave

lysergamides; mental health outcomes; phenethylamines; psychedelic-assisted therapy; tryptamines

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Psychiatry Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google